- Featured Product
- KD/KO Validated
LPXN Rekombinanter Antikörper
LPXN Rekombinant Antikörper für WB, IF/ICC, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IF/ICC, ELISA
Konjugation
Unkonjugiert
CloneNo.
240483G10
Kat-Nr. : 83657-5-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83657-5-PBS bindet in WB, IF/ICC, ELISA LPXN und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | LPXN fusion protein Ag34956 |
| Vollständiger Name | leupaxin |
| Berechnetes Molekulargewicht | 43 kDa |
| Beobachtetes Molekulargewicht | 45 kDa |
| GenBank-Zugangsnummer | BC019035 |
| Gene symbol | LPXN |
| Gene ID (NCBI) | 9404 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
LPXN, also known as Leupaxin, LDPL, belongs to the paxillin family. LPXN Contributes to the regulation of cell adhesion, spreading, and cell migration and acts as a negative regulator in integrin-mediated cell adhesion events (PMID: 20543562). LPXN has four leucine-rich LD-motifs in the N-terminus and four LIM domains in the C-terminus. It may function in cell type-specific signaling by associating with PYK2, a member of the focal adhesion kinase family (PMID: 9565592). Studies in breast cancer implicate LPXN is involved in the regulation of ER action as a co-factor (PMID: 25955236). LPXN is expressed in prostate cancer cells and its expression intensity is directly linked to PCa progression (PMID: 18451096).







